Digestible Smart Chip Monitors Gut Health: New Era of Non-Invasive Digestive Diagnosis

Israeli medtech firm Given Imaging has unveiled GutSense, a swallowable electronic capsule no larger than a vitamin pill that monitors pH levels, temperature, enzyme activity, and microbiome metabolites as it traverses the gastrointestinal tract.

The device contains a biodegradable microchip powered by gastric fluid, eliminating the need for a battery. Data is transmitted in real time to a smartphone app via low-energy Bluetooth relayed through a small adhesive patch worn on the abdomen. The capsule dissolves harmlessly within 72 hours.

In a clinical validation study published in Nature Medicine, GutSense was tested on 340 patients undergoing evaluation for irritable bowel syndrome, celiac disease, and small intestinal bacterial overgrowth. The capsule's diagnostic findings matched those obtained through conventional endoscopy and breath testing in 91% of cases.

"GutSense gives us a continuous, segment-by-segment map of what's happening inside the gut without sedation, radiation, or invasive procedures," said Dr. Yael Bar-Shavit, a gastroenterologist at Sheba Medical Center who led the study.

The technology could be particularly valuable for pediatric patients and elderly individuals who cannot tolerate traditional endoscopy. Given Imaging has submitted a regulatory application to the European Medicines Agency and expects CE marking by the fourth quarter of 2028. FDA clearance is anticipated in early 2029.

The company plans to price the capsule at approximately $150 per unit, significantly below the cost of a standard endoscopic procedure. Analysts at Piper Sandler estimate the addressable market for non-invasive GI diagnostics could reach $8 billion annually by 2031.